Report of the international conference on next generation sequencing for adventitious virus detection in biologicals

Biologicals

Volumn 55, Issue , 2018, Pages 1-16

  Khan, Arifa S ^a   Benetti, Luca ^b   Blumel, Johannes ^c   Deforce, Dieter ^d   Egan, William M ^e   Knezevic, Ivana ^f   Krause, Philip R ^a   Mallet, Laurent ^g   Mayer, Dietmar ^h   Minor, Philip D ⁱ   Neels, Pieter ^j   Wang, Guanhua ^k  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c PAUL EHRLICH INSTITUT   (Germany)

^d GHENT UNIVERSITY   (Belgium)

^e GLAXOSMITHKLINE   (United States)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g SANOFI PASTEUR   (France)

^h IDT Biologika GmbH   (Germany)

ⁱ NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^j International Alliance for Biological Standardization (IABS)   (Switzerland)

^k HEALTH CANADA   (Canada)

more..

Author keywords

Adventitious viruses; Bioinformatics; Biologics; Biotherapeutics; Cell substrate; High throughput sequencing; Next generation sequencing; Vaccines

Indexed keywords

BIOLOGICAL PRODUCT;

ADVENTITIOUS VIRUS; BIOINFORMATICS; CONFERENCE PAPER; DATA BASE; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE ORGANIZATION; INFORMATION PROCESSING; MEDICAL EDUCATION; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; PRODUCT SAFETY; SCIENTIST; STANDARDIZATION; UNITED STATES; VIRAL CONTAMINATION; VIRUS; VIRUS DETECTION; ADENOVIRIDAE; ANIMAL; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; ORGANIZATION;

ADENOVIRIDAE; ANIMALS; CONGRESSES AS TOPIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85050985756     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2018.08.002     Document Type: Conference Paper

References (40)

1. Khan, A.S., King, K.E., Brack, K., Cassart, J.-P., Chiu, C., Dehghani, H., Duncan, P., Jaing, C., Kolman, J., Munroe, D., Palermo, A., Plavsic, M., Sampath, R., Slezak, T., Takle, G., Taliaferro, L.P., Toso, E., Vacante, D., Willkommen, H., Emerging methods for virus detection., 2015, 71 PDA Technical Report.
2. King, K., Wiebe, M., Cell Substrate Task, F., Introduction: PDA cell substrate workshop proceedings. PDA J Pharm Sci Technol, 64, 2010, 374.
3. Wiebe, M., King, K., Cell Substrate Task, F., Synthesis session. PDA J Pharm Sci Technol 64 (2010), 492–494.
4. Sheets, R., Loewer, J., Raychaudhuri, G., Petricciani, J., Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MD. Biologicals 40 (2012), 162–167.
5. Khan, A.S., Lubiniecki, A., King, K.E., PDA/FDA adventitious agents and novel cell substrates: emerging technologies and new challenges, nov. 3-4, 2011, Rockville, MD. PDA J Pharm Sci Technol 66 (2012), 502–511.
6. US Food and Drug Administration, FDA briefing document: vaccines and related biological products advisory committee meeting: cell lines derived from human tumors for vaccine manufacture. 2012 http://wwwfdagov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM319573pdf.
7. Khan, A.S., Vacante, D.A., Introduction and workshop summary: advanced technologies for virus detection in the evaluation of biologicals-applications and challenges. PDA J Pharm Sci Technol 68 (2014), 546–547.
8. Khan, A.S., Vacante, D.A., Cassart, J.P., Ng, S.H., Lambert, C., Charlebois, R.L., et al. Advanced virus detection technologies interest group (AVDTIG): efforts for high throughput sequencing (HTS) for virus detection. PDA J Pharm Sci Technol 70:6 (2016), 591–595.
9. Guidance for Industry, Characterizatoin and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. 2010 http://wwwfdagov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm202439pdf.
10. Victoria, J.G., Wang, C., Jones, M.S., Jaing, C., McLoughlin, K., Gardner, S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 84 (2010), 6033–6040.
11. Ma, H., Galvin, T.A., Glasner, D.R., Shaheduzzaman, S., Khan, A.S., Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines. J Virol 88 (2014), 6576–6585.
12. Khan, A.S., Ng, S.H.S., Vandeputte, O., Aljanahi, A., Deyati, A., Cassart, J.P., et al. A multicenter study to evaluate the performance of high-throughput sequencing for virus detection. mSphere, 2, 2017.
13. Goodacre, N., Aljanahi, A., Nandakumar, S., Mikailov, M., Khan, A.S., A reference viral database (RVDB) to enhance bioinformatics analysis of high-throughput sequencing for novel virus detection. mSphere, 3, 2018.
14. Petricciani, J., Sheets, R., Griffiths, E., Knezevic, I., Adventitious agents in viral vaccines: lessons learned from 4 case studies. Biologicals 42 (2014), 223–236.
15. WHO Expert Committee on Biological Standardization, Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for hte characterization of cell banks. 2010, WHO Technical Report Technical Series No. 978 Annex 3.
16. WHO Expert Committee on Biologoical Strandardization, Scientific principles for regulatory risk evaluation on finding an adventitious agent in a marketed vaccine, 993, 2015, WHO Technical Report Technical Series Annex 2.
17. European Pharmacopoeia, Vaccines for human use, monograph no 153. European pharmacopoeia, ninth ed., 2017 9.3, 2017.
18. EMA Guideline on the principles of regulatory acceptance of 3Rs (Replacement R, Refinement) testing approaches (EMA/CHMP/CVMP/JEG-3Rs/450091/2012), 2016 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2017/03/WC500224306.pdf.
19. Gombold, J., Karakasidis, S., Niksa, P., Podczasy, J., Neumann, K., Richardson, J., et al. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. Vaccine 32 (2014), 2916–2926.
20. Sheets, R., Duncan, P.A., Vaccine analysis: strategies, principles, and control. 2015, Springer-Verlag, Berllin, Heidelberg.
21. European Pharmacopoeia, General chapter 5.2.14 Substitution of in vivo methods by in vitro methods for the quality control of vaccines. European pharmacopoeia, ninth ed., 2017 9.3.
22. Marston, D.A., Ellis, R.J., Horton, D.L., Kuzmin, I.V., Wise, E.L., McElhinney, L.M., et al. Complete genome sequence of Ikoma lyssavirus. J Virol 86 (2012), 10242–10243.
23. Marston, D.A., Mansfield, K.L., Mearns, R., Ellis, R.J., Fooks, A.R., Johnson, N., Louping ill virus genome sequence derived from the spinal cord of an infected lamb. Genome Announc, 1, 2013.
24. Filippone, C., Castel, G., Murri, S., Beaulieux, F., Ermonval, M., Jallet, C., et al. Discovery of hantavirus circulating among Rattus rattus in French Mayotte island, Indian Ocean. J Gen Virol 97 (2016), 1060–1065.
25. Bouzon Alejandro, M., Diez Domingo, J., Martinon-Torres, F., Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain. Hum Vaccine 7 (2011), 798–799.
26. European Medicines Agency, Guideline on the use of porcine trypsin used in the manufacture of human biological medicinal products. 20 February 2014.
27. Mee, E.T., Preston, M.D., Minor, P.D., Schepelmann, S., Participants, C.S.S., Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing. Vaccine 34 (2016), 2035–2043.
28. Norling, M., Karlsson-Lindsjo, O.E., Gourle, H., Bongcam-Rudloff, E., Hayer, J., MetLab: an in silico experimental design, simulation and analysis tool for viral metagenomics studies. PLoS One, 11, 2016, e0160334.
29. Karlsson, O.E., Larsson, J., Hayer, J., Berg, M., Jacobson, M., The intestinal eukaryotic virome in healthy and diarrhoeic neonatal piglets. PLoS One, 11, 2016, e0151481.
30. Mollerup, S., Fridholm, H., Vinner, L., Kjartansdottir, K.R., Friis-Nielsen, J., Asplund, M., et al. Cutavirus in cutaneous malignant melanoma. Emerg Infect Dis 23 (2017), 363–365.
31. Ng, T.F., Kondov, N.O., Deng, X., Van Eenennaam, A., Neibergs, H.L., Delwart, E., A metagenomics and case-control study to identify viruses associated with bovine respiratory disease. J Virol 89 (2015), 5340–5349.
32. Bouzalas, I.G., Wuthrich, D., Walland, J., Drogemuller, C., Zurbriggen, A., Vandevelde, M., et al. Neurotropic astrovirus in cattle with nonsuppurative encephalitis in Europe. J Clin Microbiol 52 (2014), 3318–3324.
33. Seuberlich, T., Wuthrich, D., Selimovic-Hamza, S., Drogemuller, C., Oevermann, A., Bruggmann, R., et al. Identification of a second encephalitis-associated astrovirus in cattle. Emerg Microb Infect, 5, 2016 e71.
34. Besch-Williford, C., Pesavento, P., Hamilton, S., Bauer, B., Kapusinszky, B., Phan, T., et al. A naturally transmitted epitheliotropic polyomavirus pathogenic in immunodeficient rats: characterization, transmission, and preliminary epidemiologic studies. Toxicol Pathol 45 (2017), 593–603.
35. O'Grady, T., Cao, S., Strong, M.J., Concha, M., Wang, X., Splinter Bondurant, S., et al. Global bidirectional transcription of the Epstein-Barr virus genome during reactivation. J Virol 88 (2014), 1604–1616.
36. Uhlenhaut, C., McClenahan, S., Krause, P.R., Use of DOP-PCR in non-specific virus detection. PDA J Pharm Sci Technol 65 (2011), 681–684.
37. Uhlenhaut, C., Cohen, J.I., Fedorko, D., Nanda, S., Krause, P.R., Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin. J Clin Virol 44 (2009), 337–339.
38. McClenahan, S.D., Uhlenhaut, C., Krause, P.R., Optimization of virus detection in cells using massively parallel sequencing. Biologicals 42 (2014), 34–41.
39. McClenahan, S.D., Uhlenhaut, C., Krause, P.R., Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing. Vaccine 32 (2014), 7115–7121.
40. Charlebois, R.L., Ng, S.H., Gisonni-Lex, L., Mallet, L., Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection. PDA J Pharm Sci Technol 68 (2014), 602–618.